QR-Code

Primary Brain Tumor Radiotherapy with Concurrent and Adjuvant Temozolomide: Its Outcomes in Terms of Survival and Toxicity

Background: To assess the outcome of primary brain tumor radiotherapy with concurrent and adjuvant temozolomide. Material and Methods: A total of 42 patients who were histologically proven primary malignant brain tumor with nonmetastatic, ECOG (Eastern Cooperative Oncology Group) performance status...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Manraj S. Kang, Simrandeep Singh, Taranjeet Kaur, Pardeep Garg, Gurpreet Kaur, Puneet Saluja
Format: Artigo
Sprache:Inglês
Veröffentlicht: Wolters Kluwer Medknow Publications 2026-04-01
Schriftenreihe:Journal of Pharmacy and Bioallied Sciences
Schlagworte:
brain tumor
radiotherapy
survival
temozolomide
toxicity
Online-Zugang:https://journals.lww.com/10.4103/jpbs.jpbs_939_24
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge